Digital Health Trials: Recommendations for Selecting and Testing a Digital Health Technology Posted on July 8, 2021February 11, 2025 by Hannah Faulkner Digital Health Trials: Recommendations for Selecting and Testing a Digital Health Technology
Digital Health Trials: Recommendations for Preparing a Site Posted on July 8, 2021October 9, 2024 by Hannah Faulkner Digital Health Trials: Recommendations for Preparing a Site
Digital Health Trials: Recommendations for Managing Data Posted on July 8, 2021February 6, 2025 by Hannah Faulkner Digital Health Trials: Recommendations for Managing Data
Digital Health Trials: Recommendations for Interacting with Regulators Posted on July 8, 2021February 5, 2025 by Hannah Faulkner Digital Health Trials: Recommendations for Interacting with Regulators
Digital Health Trials: Recommendations for Delivering an Investigational Product Posted on July 8, 2021July 8, 2021 by Hannah Faulkner Digital Health Trials: Recommendations for Delivering an Investigational Product
Recommendations for Advancing the Use of Digital Health Technologies for Data Capture and Improved Clinical Trials Posted on June 17, 2021July 8, 2021 by Hannah Faulkner Recommendations for Advancing the Use of Digital Health Technologies for Data Capture and Improved Clinical Trials
Recommendations for Decentralized Clinical Trials Posted on June 17, 2021July 8, 2021 by Hannah Faulkner Recommendations for Decentralized Clinical Trials
Recommendations for Streamlining Protocol Elements for HABP/VABP Trials Posted on June 8, 2021April 6, 2025 by Hannah Faulkner Recommendations for Streamlining Protocol Elements for HABP/VABP Trials
Recommendations for Optimizing Efficiency for Data Collection in HABP/VABP Trials Posted on June 8, 2021November 21, 2024 by Hannah Faulkner Recommendations Optimizing Efficiency for Data Collection in HABP/VABP Trials
Recommendations for Identifying Qualified Investigators and Their Delegates to Conduct Sponsored Clinical Trials Posted on June 8, 2021February 6, 2025 by Hannah Faulkner Recommendations for Identifying Qualified Investigators and Their Delegates to Conduct Sponsored Clinical Trials
